MTVA
MetaVia, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.23
−2.38%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.73
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.90
- EPS estimate
- -$0.82
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +45.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.82 | -$0.90 | Miss -9.76% | — |
| May 14, 2026 | -$0.76 | -$0.79 | Miss -3.95% | — |
| Mar 26, 2026 | -$2.06 | $1.01 | Beat 149.03% | — |
| Nov 6, 2025 | -$2.86 | -$1.54 | Beat 46.15% | — |
| Aug 7, 2025 | -$0.32 | -$0.26 | Beat 18.75% | — |
| May 14, 2025 | -$0.57 | -$0.36 | Beat 36.84% | — |
| Dec 31, 2024 | — | -$6.59 | — | — |
| Aug 14, 2024 | -$1.38 | -$1.85 | Miss -34.06% | — |
| Mar 31, 2024 | -$1.10 | -$15 | Miss -1219.21% | — |
| Dec 31, 2023 | — | -$12 | — | — |
| Sep 30, 2023 | -$0.88 | -$8.27 | Miss -840.24% | — |
| Jun 30, 2023 | -$1.04 | -$1.60 | Miss -53.46% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026